Physician

Rafael L Schmulevich, MD

According to 2025 Medicare claims, Rafael Schmulevich, MD (NPI: 1215060140) practices cardiology in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Jefferson, OH. This provider's primary affiliated billing organization is TRINITY WEST (NPI: 1043234677; TIN: 34-0875691) and primary practice location at 43952-2356.

Schmulevich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,686 traditional Medicare patients, billed 7,530 HCPCS/CPT codes, and received $233,841 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,983 prescription claims across 812 beneficiaries totaling $716,935 in drug costs, led by Eliquis (Apixaban). DME data shows 48 claims. Open Payments data shows 47 records totaling $780. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $399,398 to $233,841. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $21,517 to $15,885.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,248	9,252	$399,398
2016	2,447	10,011	$382,507
2017	2,486	10,996	$388,685
2018	2,389	10,863	$398,817
2019	2,578	11,949	$444,563
2020	2,256	10,151	$394,333
2021	1,924	9,749	$313,412
2022	1,715	8,719	$268,181
2023	1,610	7,478	$245,560
2024	1,686	7,530	$233,841

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	976	11,786	$702,666
2016	1,016	11,636	$840,691
2017	1,022	12,430	$1,027,289
2018	1,100	12,491	$1,053,476
2019	1,063	9,329	$874,181
2020	1,020	7,786	$784,415
2021	990	7,834	$893,872
2022	929	7,161	$1,005,569
2023	857	6,476	$957,851
2024	812	5,983	$716,935

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$8,208
2016	N/R	75	$3,785
2017	N/R	123	$4,636
2018	N/R	130	$5,249
2019	N/R	30	$1,945
2020	N/R	N/R	N/R
2021	N/R	13	$1,041
2022	N/R	N/R	N/R
2023	N/R	12	$1,087
2024	N/R	48	$3,152

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	644	1,156	$80
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	237	242	$53
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	443	460	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,031	1,664	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	768	1,056	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	510	21,871	$414,093
Xarelto	Rivaroxaban	90	3,862	$71,831
Brilinta	Ticagrelor	113	4,668	$67,598
Entresto	Sacubitril/Valsartan	66	2,940	$61,058
Jardiance	Empagliflozin	19	736	$15,018

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	27	$2,561
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	21	$591

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$780	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rafael L. Schmulevich, MD?

Tedicare shows public-source Medicare data for Rafael L. Schmulevich, MD (NPI 1215060140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rafael L. Schmulevich, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rafael L. Schmulevich, MD?

Rafael L. Schmulevich, MD is linked to TRINITY WEST (billing NPI 1043234677) in the available physician profile data.

Does Rafael L. Schmulevich, MD have Open Payments data?

Rafael L. Schmulevich, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.